Abbott India Limited
ABBOTINDIA
주식 순위
#3013
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
주가
$285.88
마지막 동기화: 2026-10-19
시가총액
$6.07B
변동 (1일)
-1.13%
변동 (1년)
-16.06%
국가
IN
거래 Abbott India Limited (ABBOTINDIA)
카테고리
Healthcare
Abbott India Limited (ABBOTINDIA)의 EPS
June 2026 기준 EPS TTM: $8.39
Abbott India Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $8.39입니다. 2024년 말에는 회사의 EPS가 $6.78였으며, 이는 2023년의 EPS $5.44와 증가입니다.
Abbott India Limited의 EPS 기록 (2004 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $8.39 | 7.79% |
| 2025 | $7.78 | 14.80% |
| 2024 | $6.78 | 24.70% |
| 2023 | $5.44 | 9.80% |
| 2022 | $4.95 | 11.52% |
| 2021 | $4.44 | 19.88% |
| 2020 | $3.70 | 21.36% |
| 2019 | $3.05 | 5.25% |
| 2018 | $2.90 | 44.45% |
| 2017 | $2.01 | 10.73% |
| 2016 | $1.81 | 5.00% |
| 2015 | $1.73 | 31.91% |
| 2014 | $1.31 | 5.59% |
| 2012 | $1.24 | 16.16% |
| 2011 | $1.07 | 7.05% |
| 2010 | $1.00 | -18.32% |
| 2009 | $1.22 | 39.18% |
| 2008 | $0.88 | -24.62% |
| 2007 | $1.16 | 32.56% |
| 2006 | $0.88 | 4.02% |
| 2005 | $0.84 | -43.86% |
| 2004 | $1.50 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $29.89 | 256.44% |
US
|
|
| $6.60 | -21.29% |
US
|
|
| $3.55 | -57.67% |
US
|
|
| $1.26 | -84.97% |
US
|
|
| $20.39 | 143.14% |
CH
|
